FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Institutional Venture Management XV, LLC
2. Issuer Name and Ticker or Trading Symbol

Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

3000 SAND HILL ROAD BLDG. 2, SUITE 250
3. Date of Earliest Transaction (MM/DD/YYYY)

11/28/2022
(Street)

MENLO PARK, CA 94025
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 11/28/2022  J(1)  7346 A (1)7346 D (2) 
Class A Common Stock 11/28/2022  J(1)  7345 A (1)7345 I By Institutional Venture Management XVI, LLC (3)
Class A Common Stock         10147758 I By Institutional Venture Partners XV, L.P. (4)
Class A Common Stock         53974 I By Institutional Venture Partners XV Executive Fund, L.P. (5)
Class A Common Stock         10201746 I By Institutional Venture Partners XVI, L.P. (6)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) Represents the receipt of shares from Jules A. Maltz that Mr. Maltz received pursuant to the Issuer's non-employee director compensation policy. Pursuant to a series of Director Compensation Assignment Agreements, Mr. Maltz has agreed to assign the beneficial interest in any equity awards granted to him for his service as director of the Issuer to Institutional Venture Management XV, LLC ("IVM XV") and Institutional Venture Management XVI, LLC ("IVM XVI").
(2) Todd C. Chaffee, Somesh Dash, Norman A. Fogelsong, Stephen J. Harrick, Eric Liaw, J. Sanford Miller and Dennis B. Phelps (collectively, the "Managing Directors") and Jules A. Maltz are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVM XV. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XV except to the extent of his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
(3) The Managing Directors and Jules A. Maltz are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVM XVI. Each of the Managing Directors disclaims beneficial ownership of these securities, except to the extent of his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
(4) IVM XV is the general partner of Institutional Venture Partners XV, L.P. ("IVP XV"). The Managing Directors and Jules A. Maltz are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV. IVM XV and each of the Managing Directors disclaims beneficial ownership of the shares held by IVP XV except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
(5) IVM XV is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV EF"). The Managing Directors and Jules A. Maltz are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV EF. IVM XV and each of the Managing Directors disclaims beneficial ownership of the shares held by IVP XV EF except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
(6) IVM XVI is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). The Managing Directors and Jules A. Maltz are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVP XVI. IVM XVI and each of the Managing Directors disclaims beneficial ownership of the shares held by IVP XVI except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Institutional Venture Management XV, LLC
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X

Institutional Venture Management XVI, LLC
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X

Chaffee Todd C
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X

Dash Somesh
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X

FOGELSONG NORMAN A
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X

Harrick Stephen J
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X

Liaw Eric
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X

Miller J Sanford
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X

Phelps Dennis B
3000 SAND HILL ROAD BLDG. 2, SUITE 250
MENLO PARK, CA 94025

X


Signatures
/s/ Tracy Hogan, as Attorney-in-Fact for Institutional Venture Management XV, LLC11/30/2022
**Signature of Reporting PersonDate

Institutional Venture Management XVI, LLC, By: /s/Tracy Hogan, Attorney-In-Fact11/30/2022
**Signature of Reporting PersonDate

/s/ Tracy Hogan, Attorney-In-Fact Todd C. Chaffee11/30/2022
**Signature of Reporting PersonDate

/s/ Tracy Hogan, Attorney-In-Fact Somesh Dash11/30/2022
**Signature of Reporting PersonDate

/s/ Tracy Hogan, Attorney-In-Fact Norman A. Fogelsong11/30/2022
**Signature of Reporting PersonDate

/s/ Tracy Hogan, Attorney-In-Fact Stephen J. Harrick11/30/2022
**Signature of Reporting PersonDate

/s/ Tracy Hogan, Attorney-In-Fact Eric Liaw11/30/2022
**Signature of Reporting PersonDate

/s/ Tracy Hogan, Attorney-In-Fact J. Sanford Miller11/30/2022
**Signature of Reporting PersonDate

/s/ Tracy Hogan, Attorney-In-Fact Dennis B. Phelps11/30/2022
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Hims and Hers Health (NYSE:HIMS)
Historical Stock Chart
Von Feb 2024 bis Mär 2024 Click Here for more Hims and Hers Health Charts.
Hims and Hers Health (NYSE:HIMS)
Historical Stock Chart
Von Mär 2023 bis Mär 2024 Click Here for more Hims and Hers Health Charts.